Beximco Pharmaceuticals (DHA:BXPHARMA) Other Operating Expense : BDT5,260 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Other Operating Expense?

Beximco Pharmaceuticals's Other Operating Expense for the three months ended in Mar. 2024 was BDT87 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was BDT5,260 Mil.

Beximco Pharmaceuticals's quarterly Other Operating Expense declined from Jun. 2023 (BDT5,077 Mil) to Dec. 2023 (BDT96 Mil) and declined from Dec. 2023 (BDT96 Mil) to Mar. 2024 (BDT87 Mil).

Beximco Pharmaceuticals's annual Other Operating Expense increased from Jun. 2021 (BDT3,391 Mil) to Jun. 2022 (BDT4,479 Mil) and increased from Jun. 2022 (BDT4,479 Mil) to Jun. 2023 (BDT4,960 Mil).

Beximco Pharmaceuticals Other Operating Expense Historical Data

The historical data trend for Beximco Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Other Operating Expense Chart

Beximco Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Operating Expense

Get a 7-Day Free Trial

2,685.11

3,023.17

3,390.65

4,479.09

4,960.27

Beximco Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															83.09	66.37	5,077.02	96.31	86.90

Beximco Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT5,260 Mil.

Beximco Pharmaceuticals Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Other Operating Expense

Traded in Other Exchanges

BXP:UK R2WA:Germany

Address

19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205

Website

https://www.beximcopharma.com

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines